Literature DB >> 11377136

Fenofibrate in hyperlipidaemia secondary to HIV protease inhibitors. Fenofibrate and HIV protease inhibitor.

D A de Luis, P Bachiller, R Aller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11377136     DOI： 10.1016/s0899-9007(01)00582-2

Source DB:  PubMed          Journal:  Nutrition        ISSN： 0899-9007            Impact factor:   4.008


× No keyword cloud information.
  5 in total

Review 1.  An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature.

Authors:  Christine B Bruno; Jeffrey M Schapiro; Parya Saberi
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2011-04-25

2.  Management of dyslipidemia in HIV-infected patients.

Authors:  Carlos D Malvestutto; Judith A Aberg
Journal:  Clin Lipidol       Date:  2011-08

Review 3.  Lipid management in patients who have HIV and are receiving HIV therapy.

Authors:  Judith A Aberg
Journal:  Endocrinol Metab Clin North Am       Date:  2009-03       Impact factor: 4.741

Review 4.  Evaluation and management of dyslipidemia in patients with HIV infection.

Authors:  Michael L Green
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

Review 5.  Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.

Authors:  Gillian M Keating; Douglas Ormrod
Journal:  Drugs       Date:  2002       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.